alendronate has been researched along with Carotid Artery Narrowing in 4 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Particulated dosage forms of bisphosphonates, such as polymeric nanoparticles and liposomes, deplete circulating monocytes and attenuate inflammation." | 5.34 | Additive-free albumin nanoparticles of alendronate for attenuating inflammation through monocyte inhibition. ( Golomb, G; Koroukhov, N; Markovsky, E, 2007) |
| " Intravenous (IV) and intraperitoneal (IP) liposomal alendronate (LA) treatments have been shown to deplete circulating monocytes and peritoneal macrophages resulting in the inhibition of restenosis and endometriosis (EM), respectively." | 3.76 | Route of administration-dependent anti-inflammatory effect of liposomal alendronate. ( Afergan, E; Ben-David, M; Epstein, H; Golomb, G; Gutman, D; Haber, E; Koroukhov, N; Schachter, M, 2010) |
| "Particulated dosage forms of bisphosphonates, such as polymeric nanoparticles and liposomes, deplete circulating monocytes and attenuate inflammation." | 1.34 | Additive-free albumin nanoparticles of alendronate for attenuating inflammation through monocyte inhibition. ( Golomb, G; Koroukhov, N; Markovsky, E, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen-Sela, E | 1 |
| Chorny, M | 1 |
| Koroukhov, N | 3 |
| Danenberg, HD | 1 |
| Golomb, G | 3 |
| Haber, E | 1 |
| Afergan, E | 1 |
| Epstein, H | 1 |
| Gutman, D | 1 |
| Ben-David, M | 1 |
| Schachter, M | 1 |
| Shimshi, M | 1 |
| Abe, E | 1 |
| Fisher, EA | 1 |
| Zaidi, M | 1 |
| Fallon, JT | 1 |
| Markovsky, E | 1 |
4 other studies available for alendronate and Carotid Artery Narrowing
| Article | Year |
|---|---|
A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles.
Topics: Acetates; Alendronate; Animals; Biological Availability; Bone Density Conservation Agents; Carotid S | 2009 |
Route of administration-dependent anti-inflammatory effect of liposomal alendronate.
Topics: Alendronate; Animals; Anti-Inflammatory Agents; Carotid Stenosis; Chemistry, Pharmaceutical; Disease | 2010 |
Bisphosphonates induce inflammation and rupture of atherosclerotic plaques in apolipoprotein-E null mice.
Topics: Alendronate; Animals; Aorta; Apolipoproteins E; Arteriosclerosis; Carotid Stenosis; Diphosphonates; | 2005 |
Additive-free albumin nanoparticles of alendronate for attenuating inflammation through monocyte inhibition.
Topics: Albumins; Alendronate; Animals; Carotid Stenosis; Cell Line; Cross-Linking Reagents; Diffusion; Drug | 2007 |